Menu Search
Equities

Epsilon Healthcare Ltd

9TH0:DEU

Epsilon Healthcare Ltd

Actions
  • Price (EUR)0.015
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change+114.29%
  • Beta--
Data delayed at least 15 minutes, as of Dec 18 2023.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Epsilon Healthcare Ltd had net income fall 43.77% from a loss of 9.24m to a larger loss of 13.29m despite a 29.36% increase in revenues from 5.50m to 7.11m. An increase in the cost of goods sold as a percentage of sales from 65.02% to 82.50% was a component in the falling net income despite rising revenues.
Gross margin37.99%
Net profit margin-82.17%
Operating margin-66.06%
Return on assets-31.54%
Return on equity-60.10%
Return on investment-46.30%
More ▼

Cash flow in AUDView more

In 2022, cash reserves at Epsilon Healthcare Ltd fell by 1.47m. Cash Flow from Financing totalled 1.61m or 22.60% of revenues. In addition the company used 2.57m for operations while cash used for investing totalled 529.40k.
Cash flow per share-0.0122
Price/Cash flow per share--
Book value per share0.0305
Tangible book value per share0.0305
More ▼

Balance sheet in AUDView more

Epsilon Healthcare Ltd has a Debt to Total Capital ratio of 23.29%, a higher figure than the previous year's 2.71%.
Current ratio0.5432
Quick ratio0.5237
Total debt/total equity0.3035
Total debt/total capital0.2329
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.